Vivelle and abdominal pain Patient Reports February 10, 2012

Vivelle Side Effects Report #4757524-7
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2005. Female patient, 59 years of age, was diagnosed with osteoporosis  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal pain , bilirubinuria, gallbladder disorder, hepatobiliary disease, liver function test abnormal. Vivelle dosage: 0.025 MG/DAY, BIW. Patient recovered.

Vivelle Side Effects Report #4762838-0
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2005. Female patient, 59 years of age, was diagnosed with osteoporosis  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, biliary dyskinesia, bilirubinuria, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, fatigue. Vivelle dosage: 0.025 MG/DAY, BIW. Patient recovered.

Vivelle Side Effects Report #4798905-5
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2005. Female patient, 59 years of age, was diagnosed with osteoporosis  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, biliary dyskinesia, bilirubinuria, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, chronic lymphocytic leukaemia. Vivelle dosage: 0.025 MG/DAY, BIW. Patient recovered.

Vivelle Side Effects Report #4848048-7
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2005. Female patient, 59 years of age, was diagnosed with osteoporosis  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, biliary dyskinesia, bilirubinuria, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, fatigue. Vivelle dosage: 0.025 MG/DAY, BIW. Patient recovered.


Vivelle Side Effects Report #4865887-7
Vivelle side effect was reported by a Physician from UNITED STATES on Aug 23, 2005. Female patient, 59 years of age, was diagnosed with osteoporosis  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, biliary dyskinesia, bilirubinuria, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, chronic lymphocytic leukaemia. Vivelle dosage: 0.025 MG/DAY, BIW. Patient recovered.

Vivelle Side Effects Report #4930005-3
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 23, 2005. Female patient, 59 years of age, was diagnosed with osteoporosis  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal pain , alanine aminotransferase increased, aspartate aminotransferase increased, biliary dyskinesia, bilirubinuria, blood alkaline phosphatase increased, blood bilirubin increased, chromaturia, fatigue. Vivelle dosage: 0.025 MG/DAY, BIW. Patient recovered.

Vivelle Side Effects Report #5252924-3
Vivelle side effect was reported by a Physician from UNITED STATES on Feb 22, 2007. Female patient, 67 years of age, weighting 212.0 lb, was diagnosed with menopausal symptoms, arthritis  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal pain , alopecia, blood cholesterol increased, cholecystectomy, cholelithiasis, fluid retention, hypothyroidism, hypotrichosis. Vivelle dosage: 0.05 MG/DAY, BIW. During the same period patient was treated with PLAQUENIL, VITAMINS. Patient recovered.

Vivelle Side Effects Report #5007634-4
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 14, 2005. Female patient, 50 years of age, was diagnosed with hysterectomy  and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , anxiety , blood pressure fluctuation, breast tenderness, dementia , fatigue, headache , hemiparesis. Vivelle dosage: 1 MG, 2X A WEEK, TRANSDERMAL. Patient recovered.

Vivelle Side Effects Report #6119289-6
Vivelle side effect was reported by a Consumer or non-health professional from FRANCE on Mar 03, 2009. Female patient, 55 years of age, was diagnosed with hot flush and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal pain , chest discomfort, fatigue, headache , hypertension, insomnia, muscle spasms, palpitations. Vivelle dosage: unknown. Patient recovered.


Vivelle Side Effects Report #5501513-1
Vivelle side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 22, 2007. Female patient, 62 years of age, weighting 140.0 lb, was diagnosed with menopausal symptoms and was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , agranulocytosis, anxiety disorder, ascites, carbohydrate antigen 125 increased, cardiac failure congestive, dyspnoea, gastrooesophageal reflux disease. Vivelle dosage: 0.05 MG, TIW. During the same period patient was treated with PREMPRO, FOSAMAX, LEVBID, DITROPAN, XANAX, ESTRADERM. Patient was hospitalized. Patient recovered.

Vivelle Side Effects Report #4643491-3
Vivelle side effect was reported by a Consumer or non-health professional from on Sept 21, 2004. Female patient was treated with Vivelle. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain , anxiety , breast tenderness, chest pain , depression , dizziness , feeling abnormal, headache . Vivelle dosage: 0.05 MG, TRANSDERMAL. Patient recovered.